REPCF

RepliCel Life Sciences Inc. REPCF

REPCF
RepliCel Life Sciences Inc. BTAX
Biostax Corp. STAB
Statera Biopharma, Inc. DNAG
DNAPrint Genomics, Inc. PANC
Panacos Pharmaceuticals, Inc. RCAR
RenovaCare, Inc. AVXT
AVAX Technologies, Inc. HSTC
HST Global, Inc. ARNI
Arno Therapeutics, Inc. ERGO
Entia Biosciences, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode REPCF BTAX STAB DNAG PANC RCAR AVXT HSTC ARNI ERGO
6M -95.00 % -50.00 % 0.00 % -50.00 % 0.00 % 0.00 % 0.00 % -99.96 % 0.00 % 100.00 %
YTD -90.00 % -99.37 % 0.00 % 900.00 % 0.00 % 0.00 % 0.00 % -99.98 % 0.00 % 0.00 %
1Y -97.67 % -99.71 % -50.00 % 900.00 % 0.00 % 0.00 % -90.00 % -99.98 % -66.67 % 0.00 %
3Y -98.88 % -99.99 % -99.95 % 900.00 % 900.00 % -99.81 % -90.00 % -99.84 % 9 900.00 % -71.43 %
5Y -99.08 % -100.00 % -100.00 % -99.00 % 900.00 % -100.00 % -99.63 % -99.79 % -93.33 % -98.11 %
10Y -99.96 % -100.00 % -100.00 % -99.00 % 900.00 % -99.99 % -99.95 % -99.37 % -99.97 % -99.80 %
From the beginning -99.94 % -100.00 % -100.00 % -100.00 % -99.99 % -99.99 % -100.00 % -100.00 % -100.00 % -99.99 %

Dividend